Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000028

Chief Medical Officer gave up 2,368 shares (to pay taxes)

  • Chief Medical Officer acquired 5,280 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-13 Exercise or conversion : show line 1 in the form +5,280 10,598 D
2020-04-14 Shares withheld for taxes : show line 2 in the form −2,368 $40.64 $96,236 8,230 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-13 Exercise or conversion : show line 3 in the form Performance share units −5,280 10,561 D
Loading xslF345X03/wf-form4_158698231920894.xml…